Alternative Market Access Strategy Lead

UCB•Atlanta, GA

7d•$164,000 - $216,000•Hybrid

About The Position

At UCB, we believe every patient deserves timely, affordable, and seamless access to the therapies that change lives. The Market Access Strategy Lead, DTP (Direct to Patient) will report to the Alternative Access Strategy Lead and will help redefine how care reaches people by turning barriers into bridges. DTP is an essential complement to UCB’s longstanding commitment to patient-centric access and to broader industry progress, meeting rising expectations for convenience, transparency, and choice. In this role, you will shape our vision for a future where medicines are easier to reach, powered by innovative partnerships and modern digital platforms that extend care beyond traditional channels. Your leadership will put patients first by accelerating access, removing friction, and improving time to therapy, affordability, and adherence so more people can live their best lives.

Requirements

Bachelor’s degree in Business, Health Policy, Pharmacy, Data/Analytics, or related field (MBA/MPH a plus).
10+ years of biopharma experience, with significant expertise in Market Access, Trade/Supply Chain, Channel Strategy, Patient
Support/HUB, Specialty Pharmacy, Digital Health, or adjacent access and fulfillment domains.

Nice To Haves

Demonstrated ability to design or navigate patient access solutions that improve affordability, time to therapy, and adherence within U.S. healthcare channels.
Strong analytical skills with fluency in forecasting, pricing constructs, gross-to-net drivers, and performance dashboards.
Working knowledge of U.S. regulatory and compliance considerations relevant to patient access and distribution (for example, pharmacy and telehealth rules, price reporting sensitivities, privacy).
Proven ability to manage and influence a broad range of stakeholders across multiple functions and levels, driving alignment and execution on complex initiatives.
Excellent communication, influence, and storytelling skills with a track record of aligning cross-functional teams around clear, patient-first decisions.

Responsibilities

Define the long-term vision and roadmap for DTP across UCB’s U.S. portfolio, ensuring alignment with patient centric access principles and corporate objectives.
Build compelling business cases for investment in DTP initiatives, including pilots and scaleup strategies.
Lead cross-functional integration for patient impact
Drive collaboration with Market Access, Trade, Policy, Legal, Compliance, Finance, IT/Digital, and Business Units to embed DTP into launch and lifecycle planning.
Ensure seamless alignment between affordability solutions, reimbursement pathways, and patient support programs.
Develop innovative DTP program designs that prioritize speed to therapy, affordability, and adherence while balancing risk/benefit to UCB.
Serve as UCB’s subject matter expert on DTP partners and models.
Use analytics to inform pricing constructs, channel strategies, and forecasting; anticipate DTP impact on gross to net and overall brand performance.
Establish KPIs focused on patient outcomes and experience; monitor performance and recommend optimizations based on insights and ROI.
Integrate DTP considerations into launch strategies for new products; lead test and learn pilots and scale successful models across brands.
Partner with marketing and patient engagement teams to ensure messaging reflects the value of DTP for patients and caregivers
Align strategy with legal, compliance, and regulatory requirement
Champion innovation and continuous improvement